BRAF35 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BRAF35 monoclonal antibodies for investigating BRAF protein's role in cellular signaling pathways. BRAF35 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRAF is a critical component of the MAPK/ERK signaling pathway, which regulates cell division, differentiation, and secretion. Mutations in the BRAF gene are commonly associated with several cancers, making BRAF35 monoclonal antibodies essential for studying tumor biology and developing targeted therapies. Understanding BRAF function can provide insights into disease mechanisms and potential treatment strategies. BRAF35 monoclonal antibodies enable precise detection and analysis of BRAF expression patterns across various experimental conditions. Researchers can utilize BRAF35 monoclonal antibodies to examine protein-protein interactions and cellular localization patterns. BRAF35 monoclonal antibodies support detailed mapping of signaling cascades and molecular mechanisms. Santa Cruz Biotechnology's BRAF35 monoclonal antibodies empower researchers worldwide to advance cancer research and therapeutic development.